TipRanks
Dongsung Pharmaceutical Co., Ltd. (KR:002210)
:002210
South Korea Market
002210
Dongsung Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Dongsung Pharmaceutical Co., Ltd. (002210) Ratios

― Followers

Dongsung Pharmaceutical Co., Ltd. Ratios

KR:002210's free cash flow for Q2 2026 was ₩0.37. For the 2026 fiscal year, KR:002210's free cash flow was decreased by ₩ and operating cash flow was ₩-0.17. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.24 0.69 0.88 1.36 1.14
Quick Ratio
 0.94 0.54 0.59 0.92 0.83
Cash Ratio
 0.58 0.03 0.04 0.14 0.09
Solvency Ratio
 -0.13 -0.16 -0.06 >-0.01 >-0.01
Operating Cash Flow Ratio
 -0.39 -0.10 -0.13 -0.10 -0.08
Short-Term Operating Cash Flow Coverage
 -0.65 -0.20 -0.19 -0.17 -0.13
Net Current Asset Value
₩ 8.26B₩ -56.18B₩ -28.58B₩ -14.36B₩ -10.50B
Leverage Ratios
Debt-to-Assets Ratio
 0.24 0.38 0.34 0.38 0.34
Debt-to-Equity Ratio
 0.44 2.74 0.94 1.09 0.87
Debt-to-Capital Ratio
 0.31 0.73 0.49 0.52 0.46
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.01 0.32 0.15
Financial Leverage Ratio
 1.83 7.21 2.75 2.89 2.52
Debt Service Coverage Ratio
 -0.01 -0.24 -0.03 0.08 0.04
Interest Coverage Ratio
 -1.05 -2.35 -1.76 0.27 -1.56
Debt to Market Cap
 1.24 2.88 0.49 0.32 0.24
Interest Debt Per Share
 495.97 3.23K 2.44K 1.99K 1.67K
Net Debt to EBITDA
 -0.18 -2.91 -23.88 10.77 21.57
Profitability Margins
Gross Profit Margin
41.24%41.71%43.96%46.70%45.06%
EBIT Margin
-10.33%-26.23%-4.43%1.55%-0.58%
EBITDA Margin
-7.88%-23.78%-2.32%3.86%1.64%
Operating Profit Margin
-10.33%-26.23%-7.45%0.67%-2.19%
Pretax Profit Margin
-21.34%-32.91%-8.66%-0.98%-1.98%
Net Profit Margin
-14.04%-29.53%-8.20%-2.34%-2.27%
Continuous Operations Profit Margin
-14.04%-29.53%-8.20%-2.34%-2.27%
Net Income Per EBT
65.80%89.71%94.74%239.51%114.65%
EBT Per EBIT
206.45%125.46%116.12%-145.18%90.64%
Return on Assets (ROA)
-7.21%-15.28%-4.77%-1.80%-1.97%
Return on Equity (ROE)
-18.82%-110.12%-13.14%-5.21%-4.96%
Return on Capital Employed (ROCE)
-8.96%-59.02%-8.81%0.85%-3.40%
Return on Invested Capital (ROIC)
-4.19%-19.94%-4.94%0.63%-2.28%
Return on Tangible Assets
-7.23%-15.32%-4.80%-1.82%-1.99%
Earnings Yield
-9.57%-115.68%-6.85%-1.54%-1.38%
Efficiency Ratios
Receivables Turnover
 3.76 4.01 2.46 2.83 2.82
Payables Turnover
 14.00 4.39 4.14 4.19 5.16
Inventory Turnover
 2.52 2.61 2.18 2.42 3.43
Fixed Asset Turnover
 1.13 1.21 1.20 2.07 2.12
Asset Turnover
 0.51 0.52 0.58 0.77 0.87
Working Capital Turnover Ratio
 3.63 -3.51 24.95 7.78 9.71
Cash Conversion Cycle
 216.06 147.63 227.83 192.42 164.96
Days of Sales Outstanding
 97.18 90.94 148.51 128.92 129.38
Days of Inventory Outstanding
 144.95 139.88 167.46 150.54 106.31
Days of Payables Outstanding
 26.07 83.19 88.13 87.04 70.74
Operating Cycle
 242.13 230.83 315.96 279.46 235.69
Cash Flow Ratios
Operating Cash Flow Per Share
 -268.24 -562.42 -434.84 -187.76 -168.78
Free Cash Flow Per Share
 -277.87 -619.10 -542.71 -228.15 -196.73
CapEx Per Share
 9.62 56.67 107.87 40.39 27.95
Free Cash Flow to Operating Cash Flow
 1.04 1.10 1.25 1.22 1.17
Dividend Paid and CapEx Coverage Ratio
 -27.87 -9.92 -4.03 -4.65 -6.04
Capital Expenditure Coverage Ratio
 -27.87 -9.92 -4.03 -4.65 -6.04
Operating Cash Flow Coverage Ratio
 -0.65 -0.20 -0.19 -0.10 -0.10
Operating Cash Flow to Sales Ratio
 -0.31 -0.15 -0.11 -0.05 -0.04
Free Cash Flow Yield
-83.88%-63.63%-11.72%-3.87%-2.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.36 -0.86 -14.58 -65.05 -72.64
Price-to-Sales (P/S) Ratio
 0.38 0.26 1.20 1.52 1.65
Price-to-Book (P/B) Ratio
 1.38 0.95 1.92 3.39 3.60
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.19 -1.57 -8.53 -25.86 -34.06
Price-to-Operating Cash Flow Ratio
 -4.76 -1.73 -10.65 -31.42 -39.70
Price-to-Earnings Growth (PEG) Ratio
 -0.05 >-0.01 -0.06 39.21 1.45
Price-to-Fair Value
 1.38 0.95 1.92 3.39 3.60
Enterprise Value Multiple
 -5.00 -3.98 -75.52 50.20 122.50
Enterprise Value
 32.33B 82.52B 154.82B 171.75B 187.07B
EV to EBITDA
 -5.00 -3.98 -75.52 50.20 122.50
EV to Sales
 0.39 0.95 1.75 1.94 2.00
EV to Free Cash Flow
 -1.24 -5.83 -12.48 -32.92 -41.34
EV to Operating Cash Flow
 -1.28 -6.42 -15.57 -40.00 -48.18
Tangible Book Value Per Share
 925.01 1.00K 2.38K 1.70K 1.82K
Shareholders’ Equity Per Share
 929.13 1.02K 2.41K 1.74K 1.86K
Tax and Other Ratios
Effective Tax Rate
 0.34 0.10 0.05 -1.40 -0.15
Revenue Per Share
 871.59 3.81K 3.87K 3.87K 4.06K
Net Income Per Share
 -122.37 -1.13K -317.20 -90.70 -92.23
Tax Burden
 0.66 0.90 0.95 2.40 1.15
Interest Burden
 2.06 1.25 1.96 -0.63 3.41
Research & Development to Revenue
 0.04 0.04 0.05 0.05 0.04
SG&A to Revenue
 0.47 0.63 0.31 0.30 0.31
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 2.19 0.50 1.37 2.07 1.83
Currency in KRW